Last week JAMA published the American Cancer Society (ACS) 2015 update for breast cancer screening for women at average risk. In the issue is a review by Duke researchers who conducted an evidence review supporting the guideline. Several of these authors are from general internal medicine.
The investigative group from Duke are part of the Evidence Synthesis Group in the DCRI, led by Gillian Sanders, PhD. This project was commissioned by the ACS. There is an editorial in JAMA by Keating and Pace reflecting on both the new guidelines paper and the evidence from Duke researchers in the systematic review. The DCRI further posted commentary about the findings, noting the magnitude of benefits and risks is still unclear. The lead author of the paper is DCRI’s Evan Myers, MD, MPH.
No surprise also is that the news media extensively picked up the JAMA publications. Within 48 hours the Altmetric index for the Myers paper was “46”, coming from news outlets, blogs, and tweeters. Read more from this web page posted by JAMA: http://jamanetwork.altmetric.com/details/4652348
Evan R. Myers, MD, MPH; Patricia Moorman, PhD; Jennifer M. Gierisch, PhD, MPH; Laura J. Havrilesky, MD, MHSc; Lars J. Grimm, MD; Sujata Ghate, MD; Brittany Davidson, MD; Ranee Chatterjee Mongtomery, MD; Matthew J. Crowley, MD; Douglas C. McCrory, MD, MHSc; Amy Kendrick, RN, MSN; Gillian D. Sanders, PhD. Benefits and Harms of Breast Cancer Screening: A Systematic Review. JAMA.2015;314(15):1615-1634. doi:10.1001/jama.2015.13183. [Link]
